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CROSS-BORDER TELEMEDICINE: AN UNCERTAIN FUTURE 
RICHARD L. CLELAND* 
I.  INTRODUCTION 
Imagine that technology will increase access to health care (especially for 
the underserved), expand utilization of specialty expertise, provide patients 
with rapid access to their medical records, and reduce the cost of patient care.  
These are just a few of the benefits touted for telemedicine.1  Despite these 
benefits, the future of telemedicine, the electronic rendering of individual 
patient diagnoses and treatment, is uncertain.  As demonstrated by its most 
visible form, the prescribing of ViagraTM and other drugs over the Internet, 
telemedicine may present significant challenges to existing regulatory 
frameworks.  Moreover, issues such as low levels of literacy, especially health 
literacy, and existing ethical standards raise questions about the ultimate reach 
and benefits of telemedicine.  Whether a legitimate trade in telemedicine 
services develops will ultimately depend on consumer demand and acceptance 
as well as whether providers can develop a viable economic model to deliver 
the services consumers want. 
This Article will focus on two primary issues.  The first is the regulatory 
challenge of cross-border telemedicine.  The second is the issue of literacy, or 
the lack thereof, and the implications of low levels of health literacy for the 
development of telemedicine. 
Telemedicine is not a self-defining term.  As used in this Article, it means 
using information transmitted by electronic or other means to render a written 
or otherwise documented medical opinion concerning the diagnosis or 
treatment of a patient or to actually render treatment to a patient.  Thus, as used 
here, telemedicine does not include every use of technology to exchange 
medical data.  In addition, it does not include use of the Internet or other 
electronic communication forms where there has been a previously established 
face-to-face doctor-patient relationship.  For example, it does not include every 
 
* Senior Attorney, Division of Advertising Practices, Bureau of Consumer Protection, Federal 
Trade Commission.  The remarks expressed in this Article represent the author’s views and are 
not necessarily those of the Commission or any individual Commissioner. 
 1. Federation of State Medical Boards, A Model Act to Regulate the Practice of Medicine 
Across State Lines: An Introduction and Rationale (April 1996), at http://www.fsmb.org/ 
telemed.htm (last visited Sept. 30, 2001) [hereinafter Federation of State Medical Boards]. 
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e-mail communication between a patient and provider and, in most instances, it 
does not include the transfer of medical data to consulting experts.  
Telemedicine acquires a cross-border character whenever the patient and 
physician are not located in the same state at the time the service is rendered.2 
II.  REGULATORY AND ETHICAL ISSUES 
Except where specific statutes permit such practice, a physician practicing 
cross-border telemedicine could be charged with the unlicensed practice of 
medicine.3  Strict enforcement of these laws, which require physicians to have 
full and unrestricted licenses in every state where their patients are located, 
could seriously deter the legitimate development of telemedicine.  On the other 
hand, allowing the practice to go unregulated seems unacceptable.  A patient 
who receives care from an out-of-state physician should be entitled to the same 
standard of care as a patient receiving care from an in-state physician.  In an 
attempt to address these issues, the Federation of State Medical Boards 
(FSMB), in 1996, proposed model legislation to permit cross-border medical 
practice under certain circumstances.4 
The FSMB-proposed legislation would allow a physician holding a full 
and unrestricted license in one state to practice cross-border medicine provided 
that the physician obtained a special license from the board in the state where 
the patient is located.5  The physician would be subject to the jurisdiction of 
the board in the patient’s state.  Failure to appear or produce records would be 
a basis for suspension or revocation of the license.6  Importantly, medical 
records would be subject to all the protections provided by the state where the 
patient is located.  The FSMB proposal would exempt cases of medical 
emergency, the practice of medicine on an irregular or infrequent basis, and 
practice done without compensation or the expectation of compensation.7 
Notwithstanding current licensing requirements, there is at least one area 
of cross-border telemedicine that has flourished over the past three years—the 
practice of prescribing drugs over the Internet.  Drugs such as Phentermine and 
MeridiaTM, both classified as controlled substances, as well as ViagraTM, are 
 
 2. Id. 
 3. See, e.g., Illinois v. Express Today, Inc., No. 99 CH 0452 (D. Ill. filed Oct. 21, 1999). 
 4. See Federation of State Medical Boards, supra note 1.  Few states have enacted statutes 
covering cross-border telemedicine.  An exception is Ohio.  See OHIO REV. CODE ANN. 
§ 4731.296 (Anderson 2001).  On the other hand, at least one state that specifically recognizes 
telemedicine has enacted a provision that would limit the scope of the practice of telemedicine.  
See ARIZ. REV. STAT. ANN. §§ 32-1401(25)(ss), 36-3601 et. seq. (West 2000) (prohibiting the 
prescribing of medications or medical devices requiring a prescription without a physical 
examination or previously established doctor-patient relationship). 
 5. See Federation of State Medical Boards, supra note 1. 
 6. See id. 
 7. See id. 
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being prescribed by physicians over the Internet based on nothing more than a 
patient’s answer to online questionnaires.8  Initially, some speculated that the 
questionnaires were never reviewed by a physician and that the drugs were 
simply being shipped to patients without any physician authorization.9  In the 
majority of investigations conducted to date, however, that has not been the 
case.  Rather, investigators have discovered that in most cases a licensed 
physician reviews the questionnaires and authorizes the prescriptions.10  
However, a patient who fills out an online questionnaire generally never learns 
the name of the physician authorizing the prescription until the prescription is 
received.  While it might be easy to dismiss these practices as aberrations, they 
raise important regulatory and ethical issues that must be considered as the 
field develops. 
Significantly, leading health associations have condemned the practice of 
issuing prescriptions based solely on answers to online questionnaires.  The 
American Medical Association has taken the position that “[w]eb sites that 
offer a prescription solely on the basis of a simple questionnaire” do not meet 
appropriate standards of care for issuing a prescription.11  According to the 
FSMB: 
In order to meet a standard of practice acceptable to the state medical board, 
the physician should demonstrate that there has been (1) a documented patient 
evaluation, including history and physical examination, adequate to establish 
the diagnosis for which the drug is being prescribed and identifying underlying 
conditions and contra-indications (2) sufficient dialogue between the physician 
and patient regarding treatment options and the risks and benefits of 
treatment(s) (3) a review of the course and efficacy of treatment to assess 
therapeutic outcome and (4) maintenance of a contemporaneous medical 
 
 8. There are Internet pharmacies that operate legitimately over the Internet.  These 
pharmacies typically operate like traditional “brick and mortar” or legitimate mail order 
pharmacies.  They require valid prescriptions from licensed physicians and verify the 
prescriptions before dispensing the drugs.  These pharmacies may provide substantial benefits to 
consumers, including competitive prices, access, convenience and privacy.  See Drugstores on the 
Net: The Benefits and Risks of Online Pharmacies Before the Subcommittee on Oversight and 
Investigations of the House Comm. on Commerce, 106th Cong. 3 (1999) (prepared statement of 
the Federal Trade Commission), available at www.ftc.gov/os/1999/9907/pharmacy 
testimony.htm (last visited Sept. 30, 2001). 
 9. Based on FTC investigations and author’s discussions with Food & Drug Administration 
and Department of Justice (notes on file with author). 
 10. Id. 
 11. Drugstores on the Net: The Benefits and Risks of On-Line Pharmacies Before the 
Subcommittee on Oversight and Investigations, House Comm. on Commerce, 106th Cong. (July 
30, 1999) (statement of the American Medical Association, presented by Herman I. Abromowitz, 
M.D.), available at www.ama-assn.org/ama/article/1402-4136.html (last visited Oct. 8, 2001).  
See also American Medical Association, Report of the Board of Trustees 35-A-99, Internet 
Prescribing (1999), available at http://www.ama-assn.org/meetings/public/annual99/reports/ 
onsite/bot/rft/bot35.rtf (last visited Nov. 10, 2001). 
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record that is readily available to patients and their other health care 
professionals.12 
Applying this standard, the FSMB concluded that the “prescribing of 
medications by physicians based solely on an electronic medical questionnaire 
clearly fails to meet an acceptable standard of care and is outside the bounds of 
professional conduct.”13  As discussed below, it is apparent that the standard 
applied by the FSMB has significant implications for more than just the 
prescribing of Viagra™ over the Internet. 
Historically, states have regulated the practice of medicine and 
pharmacy.14  Accordingly, a number of states have actively challenged online 
companies that dispense prescription drugs without a valid prescription.  
Kansas,15 Missouri, and Illinois have each filed actions against so-called 
Internet pharmacies, and Michigan issued letters of intent to sue to seventeen 
sites.16  In the Illinois cases, the out-of-state licensed physicians were charged 
with the unlicensed practice of medicine.17  Other state actions have been 
based on violations of state consumer protection statutes as well as on state 
medical and pharmacy laws.18  In addition, professional disciplinary actions 
have been initiated in at least a dozen states.19  For example, an Oregon 
physician was put on ten years probation and fined five thousand dollars for 
prescribing drugs online without an examination.20 
A case filed by the Federal Trade Commission (FTC) against an online 
drug dispenser illustrates at least one type of telemedicine currently being 
practiced.21  Under the Federal Trade Commission Act, the FTC can initiate 
 
 12. Federation of State Medical Boards, Report of the Special Committee on Professional 
Conduct and Ethics, Section IV (April 15, 2000), available at http://www.fsmb.org (last visited 
Sept. 30, 2001) [hereinafter Report on Professional Conduct & Ethics]. 
 13. Id. 
 14. E-Drugs:  Who Regulates Internet Pharmacies:  Hearing Before the House Comm. On 
Health, Education, Labor, and Pensions, 107th Cong. (2000) (testimony of Kansas Attorney 
General Carla J. Stovall), available at http://labor.senate.gov/Hearings/mar00hrg/032100wt/ 
stovall/stovall.htm [hereinafter Stovall testimony]. 
 15. See, e.g., Kansas v. Focus Medical Group, Inc., No. 99C749 (D. Kan. filed June 9, 
1999). 
 16. See Stovall testimony, supra note 14. 
 17. See, e.g., Illinois v. Express Today, Inc., No. 99 CH 0452 (D. Ill. filed Oct. 21, 1999). 
 18. United States General Accounting Office, Report to Congressional Requesters, Internet 
Pharmacies: Adding Disclosure Requirements Would Aid State and Federal Oversight, GAO-01-
69 34 (Oct. 2000), available at http://www.nascsa.org/PDF/INTERNET.PDF (last visited Nov. 
11, 2001) [hereinafter GAO Report]. 
 19. Id. 
 20. Internet Viagra, PITTSBURGH POST-GAZETTE, April 2, 2000, at A-12. 
 21. FTC v. Rennert, CV-S-00-0861 JBR (D. Nev. filed July 6, 2000).  See Federal Trade 
Commission, Press Release, Online Pharmacies Settle FTC Charges (July 12, 2000), available at 
http://www.ftc.gov/opa/2000/07/iog.htm (last visited Oct. 4, 2001) [hereinafter FTC Press 
Release] 
SAINT LOUIS UNIVERSITY SCHOOL OF LAW 
2002] CROSS-BORDER TELEMEDICINE 153 
civil actions against advertisers of medical products and services, including 
telemedicine providers and online drug dispensers, who make false or 
misleading claims about the products or services they provide.22  In FTC v. 
Rennert, the Commission alleged that the defendants misrepresented the 
services they provided.23  In particular, the FTC claimed that the defendants’ 
websites falsely represented that their customers were served by a clinic with 
physicians and an on-site pharmacy. 24  The FTC’s complaint stated that the 
defendants’ customers were not served by a medical clinic or an on-site 
pharmacy.25  Instead, these defendants employed one out-of-state physician to 
review customers’ medical questionnaires.  For this service, customers were 
charged seventy-five dollars if the prescription was approved, and the doctor 
was paid ten dollars for each of the first fifty prescriptions he approved per 
week and seven dollars and fifty cents for each additional approved 
prescription request.26 
The first Congressional hearing on Internet pharmacies was held on July 
30, 1999. 27 While state and federal authorities have achieved some significant 
victories since then, patient access to such services does not appear to have 
diminished.  In fact, consumers can easily locate websites selling Viagra™ and 
other prescription drugs through common Internet search engines.28  This 
experience suggests that state licensing boards will have a difficult time 
ensuring that cross-border telemedicine providers comply with the professional 
standards articulated by the FSMB. 
 
 22. Federal Trade Commission Act, 15 U.S.C. §§ 45(a), 52 (1994). 
 23. FTC Press Release, supra note 21. 
 24. Defendants’ websites contained statements such as “Focus Medical Group is a full 
service clinic with a full time staff dealing with the treatment of sexual dysfunction.  The clinic’s 
licensed medical physicians network with an organization of physicians throughout the United 
States and Internationally” and “All of our prescriptions are filled on premises.”  See id. 
 25. Id. 
 26. In addition to prohibiting the misrepresentations alleged in the complaint, the stipulated 
final injunction requires certain disclosures, including the name, address and phone number of the 
physician, the states where the physician is licensed or authorized to practice and the states from 
which the entity will accept orders. 
 27. Drugstores on the Net: The Benefits and Risks of On-Line Pharmacies Before the House 
Commerce Comm. Subcomm. on Oversight and Investigations, 106th Cong. (July 30, 1999) 
(prepared statement of the Honorable Tom Bliley), available at http://com-notes.house.gov/ 
cchear/hearings106.nsf. 
 28. A search conducted on September 25, 2001, using the Lycos search engine, located 
numerous domestic websites selling Viagra and other prescription medications and offering 
online consultations.  These sites were listed in the first twenty-five hits or on the initial link to 
“featured” websites: http://usa-pharmacy.com/viagra/index.htm; http://weight-loss-pharmacy.net/; 
http://www.at-cost-drugs.com; http://www.1-viagra-purchase.com; http://www.drugs-
express.com/a/11722/viagra.html; http://www.medscriptsmd.com/html/viagra.html; http://buy-
phentermine-online.com/?dom=gotoviagra; http://e-scripts-md.com/index.asp?referrer=10760; 
http://www.a1viagra.com; and http://valuehealthonline.com. 
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Enforcement of existing legal and professional standards in the face of 
consumer demand and the technology of the Internet presents significant 
challenges.29  One significant factor is resources.  State regulatory bodies are 
already overloaded and may lack the expertise to investigate and prosecute 
violations.30  Some of the most significant problems include identifying the 
physicians involved and the limited ability and authority of state medical 
boards to investigate and act against physicians once they are identified.31  
Moreover, state unlicensed practice of medicine laws, allowing for injunctive 
actions and minor criminal penalties, may not be an efficient enforcement 
vehicle.  In the absence of physical injury, or other direct threats to health, 
local prosecutors may not see these cases as priorities.  All of these 
considerations raise further questions about the ability of states to regulate an 
expanding cross-border telemedicine practice. 
As noted above, both the AMA and the FSMB have condemned the 
prescribing of drugs based solely on the answers to online questions. 32  In 
addition, FSMB has published standards for issuing prescriptions online.33  
Certain of these standards—a documented patient evaluation, including a 
history and physical examination adequate to establish the diagnosis for which 
the drug is being prescribed, identifying underlying conditions and contra-
indications, and ensuring a sufficient dialogue between the physician and 
patient regarding treatment options and the risks and benefits of treatment—
could pose significant obstacles to cross-border telemedicine. While 
technological solutions may exist or may be developed to address at least some 
of these concerns, until fully developed and implemented, serious questions 
will remain. 
Some providers may try to limit the type of medical services they provide 
(or not provide certain medications at all) in order to comply with professional 
standards.  Such limitations on standard medical practice should be fully 
disclosed to patients.  For example, the health Internet ethics organization, Hi-
Ethics, Inc., states that health professionals practicing online should inform 
patients about the limitations of online health care.34  Other providers may 
claim that they are not providing medical services.  Again, this practice raises 
 
 29. Report of the President’s Working Group on Unlawful Conduct on the Internet, The 
Electronic Frontier: The Challenge of Unlawful Conduct Involving the Use of the Internet, App. 
D: Internet Sale of Prescription Drugs and Controlled Substances (Mar. 2000), available at 
http://www.usdoj.gov/criminal/cybercrime/append.htm (last visited Sept 29, 2001). 
 30. GAO Report, supra note 18, at 16. 
 31. Id. 
 32. See supra text accompanying notes 11-13. 
 33. Report on Professional Conduct & Ethics, supra note 12. 
 34. Hi-Ethics, Health Internet Ethics: Ethical Principles for Offering Internet Health 
Services to Consumers, available at http://www.hiethics.org/Principles/index.asp (last modified 
Sept. 29, 2001) (discussing the disclosure of limitations in principle thirteen). 
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difficult disclosure issues, which might conflict with reasonable patient 
expectations and unless done successfully, create risks for both the physician 
and the patient. 
The question arises, then, whether professional standards should be relaxed 
for telemedicine.  While a compelling case can probably be made for certain 
exceptions, such as emergencies and, perhaps, to serve populations that would 
not otherwise receive adequate medical treatment, the justifications seem 
lacking for lowering standards across the board.  Lowering standards for 
telemedicine would mean that patients utilizing these medical services would 
be entitled to less protection than patients using “brick and mortar” medical 
services.  From a public health perspective, there seems to be little impetus to 
go in this direction.  Of course, it is possible that lowering standards for 
telemedicine could increase pressure to lower standards for other types of 
medical services.  In this instance, the prudent policy seems to be to apply 
existing professional standards, if for no other reason, than to encourage the 
development and broad-based implementation of compliant technology. 
III.  HEALTH LITERACY 
Current e-health information and Internet services rely on text-based 
applications written at college literacy levels, which make them of limited use 
to a significant portion of our population.  The implications of limited literacy, 
particularly limited health literacy, are significant both for telemedicine and 
other health information providers.  Some have suggested that once the quality 
of e-health information matures and search costs are eliminated, informed 
consent will become redundant.35  While this may be possible for a few, it does 
not take into account more than ninety million Americans who have difficulty 
understanding basic health information.36  Many people lack sufficient skills to 
comprehend written health education materials,37 and health information on the 
Web is commonly written at levels beyond the understanding of a majority of 
readers.38  With one in five adults reading below a fifth grade level and only 
 
 35. Nicolas P. Terry, Structural and Legal Implications of E-Health, 33 J. HEALTH L. 607, 
607-08 (2000). 
 36. Peter Brandt, Engaging the New Consumer: a Pfizer Perspective, in COLUMBIA 
UNIVERSITY HEALTH CARE FORUM: THE FUTURE HEALTH CARE CONSUMER 30 (Francoise 
Simon & Lothar Krinke eds., 2000), available at http://www.hfflr.com/adobe/columbia.pdf. 
 37. See Terry, supra note 35, at 608. 
 38. See id. at 607. 
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about half reading at levels necessary to understand basic health information,39 
the lack of basic literacy presents a significant problem.40 
At least for the immediate future, telemedicine will rely almost exclusively 
on textual material to convey important information to patients.  In addition to 
requirements that currently exist, such as informed consent, others are likely to 
exist in the future, such as privacy disclosures required pursuant to Health and 
Human Service rules implementing the Health Information Portability and 
Accountability Act (HIPAA).  In any case, telemedicine providers will be 
faced with the challenge of insuring that patients understand disclosures, 
including limitations on services, and patient instructions, all without the 
benefit of visual cues available in face-to-face consultations.  This problem 
will be particularly difficult to resolve given the complexity of the patient 
information and privacy disclosures that may be required.  Moreover, it is 
likely that the legal system, as it should, will place the burden on the providers 
when there is a miscommunication.  After all, selling health services is not the 
same as selling toasters.  There is, and should be, a higher standard for health 
providers. 
Most, if not all, of these concerns can be addressed through technology and 
sensitivity to the literacy problem.  Providers could present material at a textual 
level consistent with the user’s ability to read and comprehend, and video, 
audio, and graphics can be used in many cases instead of text.  The first step in 
solving a problem is recognizing that it exits.  Too often, in the area of 
consumer protection, problems of literacy have been ignored, in part because 
there was no good solution.  The Internet may present us with novel ways to 
address this difficult challenge. 
IV.  CONCLUSION 
Telemedicine presents exciting opportunities and challenges for the 
twenty-first century.  Its future will depend on consumer demand and the 
economics of providing telemedicine services.  There is no reason to doubt that 
innovative technologies will develop to address existing professional obstacles.  
But telemedicine, particularly cross-border telemedicine, presents significant 
regulatory challenges that cannot be easily addressed.  Thus far, however, a 
comprehensive, effective strategy to address cross-border telemedicine has not 
emerged. 
 
 39. SCI. PANEL ON INTERACTIVE COMMUNICATION & HEALTH, OFFICE OF DISEASE 
PREVENTION & HEALTH PROMOTION, U.S. DEP’T OF HEALTH & HUMAN SERVS., WIRED FOR 
HEALTH AND WELL-BEING: THE EMERGENCE OF INTERACTIVE HEALTH COMMUNICATION 40 
(Thomas R. Eng & David H. Gustafson eds., 1999). 
 40. Of course, the literacy problem is not limited to health information on websites.  For 
example, privacy notices are frequently written at college reading levels.  See John Schwartz, 
Privacy Policy Notices Are Called Too Common and Too Confusing, N.Y. TIMES, May 7, 2001, 
at A1. 
